Page last updated: 2024-08-24

3-iodobenzylguanidine and Wallerian Degeneration

3-iodobenzylguanidine has been researched along with Wallerian Degeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, N; Kanazawa, I; Mitsui, J; Momose, T; Murayama, S; Saito, Y; Shibahara, J; Shimizu, J; Tsuji, S; Ugawa, Y1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Wallerian Degeneration

ArticleYear
Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease.
    Journal of the neurological sciences, 2006, Apr-15, Volume: 243, Issue:1-2

    Topics: 3-Iodobenzylguanidine; Aged; alpha-Synuclein; Autonomic Nervous System Diseases; Ganglia, Sympathetic; Heart; Humans; Iodine Radioisotopes; Lewy Bodies; Male; Myocardium; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Spinal Cord; Sympathetic Fibers, Postganglionic; Sympathetic Nervous System; Wallerian Degeneration

2006